Advertisement

OnlineFirst

In the Spotlight

Research Article

  • Research Article | AUTHOR MANUSCRIPT
    TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia
    Seongseok Yun, Nicole D Vincelette, Xiaoqing Yu, Gregory W Watson, Mario R. Fernandez, Chunying Yang, Taro Hitosugi, Chia-Ho Cheng, Audrey R Freischel, Ling Zhang, Weimin Li, Hsinan Hou, Franz X Schaub, Alexis R Vedder, Ling Cen, Kathy L. McGraw, Jungwon Moon, Daniel J. Murphy, Andrea Ballabio, Scott Harold Kaufmann, Anders E. Berglund and John L Cleveland
    Blood Cancer Discov December 21 2020 DOI:10.1158/2643-3230.BCD-20-0029

  • Research Article | AUTHOR MANUSCRIPT
    A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms
    Yihong Guan, Anand D Tiwari, James G Phillips, Metis Hasipek, Dale R Grabowski, Simona Pagliuca, Priyanka Gopal, Cassandra M Kerr, Vera Adema, Tomas Radivoyevitch, Yvonne Parker, Daniel J Lindner, Manja Meggendorfer, Mohamed Abazeed, Mikkael A. Sekeres, Omar Y Mian, Torsten Haferlach, Jaroslaw P Maciejewski and Babal K Jha
    Blood Cancer Discov December 7 2020 DOI:10.1158/2643-3230.BCD-20-0173

Research Brief

  • Research Brief | Free Article
    Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors
    Ahmad S. Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, Sanam Loghavi, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Marina Konopleva, Sherry A. Pierce, Sa A. Wang, Guilin Tang, Veronica Guerra, Bachar Samra, Naveen Pemmaraju, Elias Jabbour, Nicholas J. Short, Ghayas C. Issa, Maro Ohanian, Guillermo Garcia-Manero, Kapil N. Bhalla, Keyur P. Patel, Koichi Takahashi, Michael Andreeff, Jorge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi and Naval Daver
    Blood Cancer Discov January 19 2021 DOI:10.1158/2643-3230.BCD-20-0143

View by date

OnlineFirst articles are published online before they appear in a regular issue of the journal. Blood Cancer Discovery publishes two types of OnlineFirst articles.

OnlineFirst Author Manuscripts are PDF versions of manuscripts that have been peer reviewed and accepted for publication, but not yet copyedited or typeset, allowing readers the most rapid access to accepted papers. They appear on the OnlineFirst page as submitted by the authors. The Author Manuscript remains on the OnlineFirst page until it is either replaced by the final proof version or when the final version of the paper is published in an online issue.

Please note that while we strive to post all accepted manuscripts within two days of their acceptance, there may be editorial considerations, such as a planned press release or the need to coordinate posting of related articles, which may preclude or delay Author Manuscript posting.

Author Manuscripts are normally replaced on the OnlineFirst page by the final proof version of the article, which incorporates author corrections but is not yet paginated.

When papers are published in an issue, they are removed from the OnlineFirst page and appear in the appropriate issue's table of contents. The date of first publication appears below each title, followed by the article's unique Digital Object Identifier (DOI).

While an article is OnlineFirst, it may be cited as shown in the following example:

Elizabeth A. Platz et al. A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment (April 1, 2011) Cancer Discov, 10.1158/2159-8274.CD-10-0020.

Sign up to be notified each time OnlineFirst articles are posted in Blood Cancer Discovery.